Matches in SemOpenAlex for { <https://semopenalex.org/work/W2531942420> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- W2531942420 endingPage "16090" @default.
- W2531942420 startingPage "16090" @default.
- W2531942420 abstract "16090 Background: Docetaxel is the standard chemotherapy for HRPC. However, a standard protocol has not yet been defined for patients with DR disease. Initial reports support the use of carboplatin (C) in combination with docetaxel (D) in these patients (pts). Methods: Metastatic HRPC pts that were resistant to treatment with D were included in our retrospective analysis. Between February 2005 and December 2007, 17 pts received treatment with C AUC 5 q3wks in combination with D 75 mg/m2 q3wks or D 35 mg/m2 d1, d8, d15 q4wks. 3 pts additionally received estramustine 140 mg on 3 consecutive days in parallel to weekly applications of D. All pts were assessed for PSA response and clinical outcome. Results: Seventeen pts were identified at our institution for analysis. The median follow-up was 13 months (range: 0–31) with a median number of 4 cycles administered (range: 1–16). PSA reduction >50% was achieved in 9 pts (53%) and PSA stabilization in 5 pts (29%). 4 pts (24%) progressed without PSA response. The median duration of PSA response was 19 wks. Pts with PSA normalization or >90% reduction tended to achieve a longer PSA response (median 79 wks, range: 18–80) compared to pts with PSA stabilization or reduction by 50–90% (20 wks, range: 4–57). The most common grade 3/4 toxicities were neutropenia in 29% and thrombocytopenia in 11% of pts. Conclusions: This retrospective analysis supports the usefulness of second-line chemotherapy in HRPC. DC shows promising activity in DR pts with clinically meaningful responses. Patient Characteristics ECOG 0, No. of patients (%) 13 (76%) ECOG 1, No. of patients (%) 3 (18%) ECOG 2, No. of patients (%) 1 (6%) Liver metastases, No. of patients (%) 4 (24%) Visceral or lymphatic metastases, No. of patients (%) 6 (35%) Pain, No. of patients (%) 12 (71%) ≥2 metastatic sites, No. of patients (%) 7 (41%) Author Disclosure Employment or Leadership Consultant or Advisory Role Stock Ownership Honoraria Research Expert Testimony Other Remuneration sanofi-aventis" @default.
- W2531942420 created "2016-10-21" @default.
- W2531942420 creator A5012177478 @default.
- W2531942420 creator A5013231760 @default.
- W2531942420 creator A5026803534 @default.
- W2531942420 creator A5036484877 @default.
- W2531942420 creator A5038597396 @default.
- W2531942420 creator A5081076272 @default.
- W2531942420 creator A5089821983 @default.
- W2531942420 date "2008-05-20" @default.
- W2531942420 modified "2023-09-26" @default.
- W2531942420 title "Outcome of second-line chemotherapy with a combination of docetaxel and carboplatin (DC) in docetaxel-resistant (DR) hormone refractory prostate cancer (HRPC) patients" @default.
- W2531942420 doi "https://doi.org/10.1200/jco.2008.26.15_suppl.16090" @default.
- W2531942420 hasPublicationYear "2008" @default.
- W2531942420 type Work @default.
- W2531942420 sameAs 2531942420 @default.
- W2531942420 citedByCount "0" @default.
- W2531942420 crossrefType "journal-article" @default.
- W2531942420 hasAuthorship W2531942420A5012177478 @default.
- W2531942420 hasAuthorship W2531942420A5013231760 @default.
- W2531942420 hasAuthorship W2531942420A5026803534 @default.
- W2531942420 hasAuthorship W2531942420A5036484877 @default.
- W2531942420 hasAuthorship W2531942420A5038597396 @default.
- W2531942420 hasAuthorship W2531942420A5081076272 @default.
- W2531942420 hasAuthorship W2531942420A5089821983 @default.
- W2531942420 hasConcept C121608353 @default.
- W2531942420 hasConcept C126322002 @default.
- W2531942420 hasConcept C126894567 @default.
- W2531942420 hasConcept C141071460 @default.
- W2531942420 hasConcept C143998085 @default.
- W2531942420 hasConcept C2776694085 @default.
- W2531942420 hasConcept C2777063308 @default.
- W2531942420 hasConcept C2778239845 @default.
- W2531942420 hasConcept C2780192828 @default.
- W2531942420 hasConcept C2780201970 @default.
- W2531942420 hasConcept C2781190966 @default.
- W2531942420 hasConcept C2781451048 @default.
- W2531942420 hasConcept C2994223898 @default.
- W2531942420 hasConcept C71924100 @default.
- W2531942420 hasConcept C90924648 @default.
- W2531942420 hasConceptScore W2531942420C121608353 @default.
- W2531942420 hasConceptScore W2531942420C126322002 @default.
- W2531942420 hasConceptScore W2531942420C126894567 @default.
- W2531942420 hasConceptScore W2531942420C141071460 @default.
- W2531942420 hasConceptScore W2531942420C143998085 @default.
- W2531942420 hasConceptScore W2531942420C2776694085 @default.
- W2531942420 hasConceptScore W2531942420C2777063308 @default.
- W2531942420 hasConceptScore W2531942420C2778239845 @default.
- W2531942420 hasConceptScore W2531942420C2780192828 @default.
- W2531942420 hasConceptScore W2531942420C2780201970 @default.
- W2531942420 hasConceptScore W2531942420C2781190966 @default.
- W2531942420 hasConceptScore W2531942420C2781451048 @default.
- W2531942420 hasConceptScore W2531942420C2994223898 @default.
- W2531942420 hasConceptScore W2531942420C71924100 @default.
- W2531942420 hasConceptScore W2531942420C90924648 @default.
- W2531942420 hasIssue "15_suppl" @default.
- W2531942420 hasLocation W25319424201 @default.
- W2531942420 hasOpenAccess W2531942420 @default.
- W2531942420 hasPrimaryLocation W25319424201 @default.
- W2531942420 hasRelatedWork W1495623746 @default.
- W2531942420 hasRelatedWork W1967786039 @default.
- W2531942420 hasRelatedWork W1982849070 @default.
- W2531942420 hasRelatedWork W2010765098 @default.
- W2531942420 hasRelatedWork W2043985321 @default.
- W2531942420 hasRelatedWork W2048946840 @default.
- W2531942420 hasRelatedWork W2050529755 @default.
- W2531942420 hasRelatedWork W2471989939 @default.
- W2531942420 hasRelatedWork W2993175924 @default.
- W2531942420 hasRelatedWork W4237654482 @default.
- W2531942420 hasVolume "26" @default.
- W2531942420 isParatext "false" @default.
- W2531942420 isRetracted "false" @default.
- W2531942420 magId "2531942420" @default.
- W2531942420 workType "article" @default.